A combination of therapeutic vaccination with Ad26/MVA and stimulation of innate immune responses leads to improved virologic control and delayed rebound in SIV-infected macaques following discontinuation of antiretroviral therapy.
- Erica N. Borducchi
- Crystal Cabral
- Dan H. Barouch